Learn / MESO
NASDAQ: MESO
Mesoblast Ltd (MESO) stock, explained like you're 5
Mesoblast Ltd trades on the Nasdaq under the ticker MESO. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
- Ticker
- MESO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.9 billion dollars
Is Mesoblast Ltd a small, medium or large cap company?
No. Mesoblast Ltd is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.9 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Mesoblast Ltd makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MESO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- How (MESO) Movements Inform Risk Allocation Models (Stock Traders Daily)
- Preliminary net operational cash spend improves 85% as Mesoblast (MESO) posts Ryoncil revenue growth. (Stock Titan)
- Mesoblast Ltd ADR stock hits 52 week low at 13.03 USD (Investing.com Nigeria)
- Mesoblast shares jump as Phase 3 chronic back pain trial completes patient treatment (Yahoo Finance)
- Mesoblast schedules November 10 meeting while Mesoblast stock sits 45.33 percent below target (ad-hoc-news.de)
Follow MESO in your daily brief
Each trading day at 5 PM ET we post what happened to Mesoblast Ltd and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MESO
Questions about Mesoblast Ltd stock
What does Mesoblast Ltd do?
Mesoblast Ltd trades on the Nasdaq under the ticker MESO. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.
What is the ticker symbol for Mesoblast Ltd?
Mesoblast Ltd trades under the ticker MESO on the Nasdaq.
What is Mesoblast Ltd's market cap?
Mesoblast Ltd is a small cap stock with a market cap of about 1.9 billion dollars.
How does Mesoblast Ltd make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MESO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MESO stock every day?
Add MESO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.